549 related articles for article (PubMed ID: 31361524)
1. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway.
Liou CJ; Dai YW; Wang CL; Fang LW; Huang WC
FASEB J; 2019 Nov; 33(11):11791-11803. PubMed ID: 31361524
[TBL] [Abstract][Full Text] [Related]
2. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
Liou CJ; Lee YK; Ting NC; Chen YL; Shen SC; Wu SJ; Huang WC
Cells; 2019 May; 8(5):. PubMed ID: 31083505
[TBL] [Abstract][Full Text] [Related]
4. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
5. Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice.
Wu SJ; Huang WC; Yu MC; Chen YL; Shen SC; Yeh KW; Liou CJ
J Nutr Biochem; 2021 May; 91():108602. PubMed ID: 33548473
[TBL] [Abstract][Full Text] [Related]
6. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
7. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
8. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
9. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
10. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
11. Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice.
Liou CJ; Wu SJ; Shen SC; Chen LC; Chen YL; Huang WC
Cell Biosci; 2020; 10():114. PubMed ID: 33014333
[TBL] [Abstract][Full Text] [Related]
12. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
[TBL] [Abstract][Full Text] [Related]
13. Acacetin Protects against Non-Alcoholic Fatty Liver Disease by Regulating Lipid Accumulation and Inflammation in Mice.
Liou CJ; Wu SJ; Shen SC; Chen LC; Chen YL; Huang WC
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563076
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
15. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling.
Peng CH; Yang MY; Yang YS; Yu CC; Wang CJ
Am J Chin Med; 2017; 45(1):67-83. PubMed ID: 28161992
[TBL] [Abstract][Full Text] [Related]
16. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
17. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
Yao Y
Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
19. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
20. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
